• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

嗜酸性粒细胞衍生的白细胞介素 13 促进肺气肿。

Eosinophil-derived IL-13 promotes emphysema.

机构信息

Division of Allergy, Asthma and Clinical Immunology, Mayo Clinic Arizona, Scottsdale, AZ, USA.

Division of Respirology, Dept of Medicine, McMaster University and St Joseph's Healthcare, Hamilton, ON, Canada.

出版信息

Eur Respir J. 2019 May 30;53(5). doi: 10.1183/13993003.01291-2018. Print 2019 May.

DOI:10.1183/13993003.01291-2018
PMID:30728205
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7313423/
Abstract

The inflammatory responses in chronic airway diseases leading to emphysema are not fully defined. We hypothesised that lung eosinophilia contributes to airspace enlargement in a mouse model and to emphysema in patients with chronic obstructive pulmonary disease (COPD).A transgenic mouse model of chronic type 2 pulmonary inflammation (I5/hE2) was used to examine eosinophil-dependent mechanisms leading to airspace enlargement. Human sputum samples were collected for translational studies examining eosinophilia and matrix metalloprotease (MMP)-12 levels in patients with chronic airways disease.Airspace enlargement was identified in I5/hE2 mice and was dependent on eosinophils. Examination of I5/hE2 bronchoalveolar lavage identified elevated MMP-12, a mediator of emphysema. We showed, , that eosinophil-derived interleukin (IL)-13 promoted alveolar macrophage MMP-12 production. Airspace enlargement in I5/hE2 mice was dependent on MMP-12 and eosinophil-derived IL-4/13. Consistent with this, MMP-12 was elevated in patients with sputum eosinophilia and computed tomography evidence of emphysema, and also negatively correlated with forced expiratory volume in 1 s.A mouse model of chronic type 2 pulmonary inflammation exhibited airspace enlargement dependent on MMP-12 and eosinophil-derived IL-4/13. In chronic airways disease patients, lung eosinophilia was associated with elevated MMP-12 levels, which was a predictor of emphysema. These findings suggest an underappreciated mechanism by which eosinophils contribute to the pathologies associated with asthma and COPD.

摘要

导致肺气肿的慢性气道疾病中的炎症反应尚未完全明确。我们假设肺嗜酸性粒细胞有助于在小鼠模型中扩大气腔,并有助于慢性阻塞性肺疾病(COPD)患者发生肺气肿。

使用慢性 2 型肺部炎症的转基因小鼠模型(I5/hE2)来研究导致气腔扩大的嗜酸性粒细胞依赖性机制。进行了转化研究,以检查慢性气道疾病患者的痰液中嗜酸性粒细胞和基质金属蛋白酶(MMP)-12 水平。

在 I5/hE2 小鼠中发现了气腔扩大,并且依赖于嗜酸性粒细胞。对 I5/hE2 支气管肺泡灌洗液的检查发现 MMP-12 升高,这是肺气肿的一种介质。我们表明,嗜酸性粒细胞衍生的白细胞介素(IL)-13 促进肺泡巨噬细胞 MMP-12 的产生。I5/hE2 小鼠的气腔扩大依赖于 MMP-12 和嗜酸性粒细胞衍生的 IL-4/13。与此一致,在痰液嗜酸性粒细胞增多和 CT 肺气肿证据的 COPD 患者中,MMP-12 升高,并且与 1 秒用力呼气量呈负相关。

慢性 2 型肺部炎症的小鼠模型表现出气腔扩大,依赖于 MMP-12 和嗜酸性粒细胞衍生的 IL-4/13。在慢性气道疾病患者中,肺嗜酸性粒细胞增多与 MMP-12 水平升高相关,MMP-12 是肺气肿的预测指标。这些发现表明,嗜酸性粒细胞有助于哮喘和 COPD 相关病理的一种被低估的机制。

相似文献

1
Eosinophil-derived IL-13 promotes emphysema.嗜酸性粒细胞衍生的白细胞介素 13 促进肺气肿。
Eur Respir J. 2019 May 30;53(5). doi: 10.1183/13993003.01291-2018. Print 2019 May.
2
Interleukin-1beta causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung.白细胞介素-1β可导致成年小鼠肺部出现炎症、肺气肿和气道重塑。
Am J Respir Cell Mol Biol. 2005 Apr;32(4):311-8. doi: 10.1165/rcmb.2004-0309OC. Epub 2005 Jan 24.
3
Cys-leukotrienes promote fibrosis in a mouse model of eosinophil-mediated respiratory inflammation.半胱氨酰白三烯促进嗜酸性粒细胞介导的呼吸炎症小鼠模型中的纤维化。
Am J Respir Cell Mol Biol. 2013 Dec;49(6):1074-84. doi: 10.1165/rcmb.2013-0009OC.
4
Basophils trigger emphysema development in a murine model of COPD through IL-4-mediated generation of MMP-12-producing macrophages.嗜碱性粒细胞通过 IL-4 介导的 MMP-12 产生巨噬细胞引发 COPD 小鼠模型的肺气肿发展。
Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):13057-13062. doi: 10.1073/pnas.1813927115. Epub 2018 Dec 3.
5
A Regulatory Role of Chemokine Receptor CXCR3 in the Pathogenesis of Chronic Obstructive Pulmonary Disease and Emphysema.趋化因子受体 CXCR3 在慢性阻塞性肺疾病和肺气肿发病机制中的调节作用。
Inflammation. 2021 Jun;44(3):985-998. doi: 10.1007/s10753-020-01393-9. Epub 2021 Jan 7.
6
Impact of inflammation, emphysema, and smoking cessation on V/Q in mouse models of lung obstruction.炎症、肺气肿和戒烟对阻塞性肺疾病小鼠模型通气/血流比的影响。
Respir Res. 2014 Apr 14;15(1):42. doi: 10.1186/1465-9921-15-42.
7
Cigarette smoke-induced pulmonary inflammation and emphysema are attenuated in CCR6-deficient mice.在缺乏CCR6的小鼠中,香烟烟雾诱导的肺部炎症和肺气肿有所减轻。
J Immunol. 2006 Oct 1;177(7):4350-9. doi: 10.4049/jimmunol.177.7.4350.
8
Sputum matrix metalloproteinase-12 in patients with chronic obstructive pulmonary disease and asthma: relationship to disease severity.慢性阻塞性肺疾病和哮喘患者的痰液基质金属蛋白酶-12:与疾病严重程度的关系。
J Allergy Clin Immunol. 2012 Mar;129(3):655-663.e8. doi: 10.1016/j.jaci.2011.12.996. Epub 2012 Feb 2.
9
Eosinophilic and Neutrophilic Airway Inflammation in the Phenotyping of Mild-to-Moderate Asthma and Chronic Obstructive Pulmonary Disease.轻至中度哮喘和慢性阻塞性肺疾病表型中的嗜酸性粒细胞性和中性粒细胞性气道炎症
COPD. 2017 Apr;14(2):181-189. doi: 10.1080/15412555.2016.1260539. Epub 2016 Dec 16.
10
Matrix Metalloproteinase-28 Is a Key Contributor to Emphysema Pathogenesis.基质金属蛋白酶-28是肺气肿发病机制的关键促成因素。
Am J Pathol. 2017 Jun;187(6):1288-1300. doi: 10.1016/j.ajpath.2017.02.008. Epub 2017 Apr 8.

引用本文的文献

1
The COURSE trial and beyond: rethinking chronic obstructive pulmonary disease exacerbation management with biologics.COURSE试验及未来展望:用生物制剂重新思考慢性阻塞性肺疾病急性加重的管理
J Thorac Dis. 2025 Aug 31;17(8):6356-6363. doi: 10.21037/jtd-2025-705. Epub 2025 Aug 27.
2
Developmental immune network of airway lymphocytes and innate immune cells in patients with stable COPD.稳定期慢性阻塞性肺疾病患者气道淋巴细胞与固有免疫细胞的发育性免疫网络
Front Immunol. 2025 Jun 16;16:1614655. doi: 10.3389/fimmu.2025.1614655. eCollection 2025.
3
Signalling CD131 regulates pulmonary inflammation, alveolar cell death and emphysema in COPD.

本文引用的文献

1
Bone marrow characterization in COPD: a multi-level network analysis.COPD 患者骨髓特征:多层次网络分析。
Respir Res. 2018 Jun 15;19(1):118. doi: 10.1186/s12931-018-0824-x.
2
Chronic obstructive pulmonary disease subpopulations and phenotyping.慢性阻塞性肺疾病亚群与表型。
J Allergy Clin Immunol. 2018 Jun;141(6):1961-1971. doi: 10.1016/j.jaci.2018.02.035.
3
Matrix metalloproteinases in emphysema.肺气肿中的基质金属蛋白酶。
信号传导分子CD131调节慢性阻塞性肺疾病中的肺部炎症、肺泡细胞死亡和肺气肿。
ERJ Open Res. 2025 Jun 23;11(3). doi: 10.1183/23120541.01020-2024. eCollection 2025 May.
4
Monoclonal Antibodies for the Treatment of Chronic Obstructive Pulmonary Disease.用于治疗慢性阻塞性肺疾病的单克隆抗体
Pulm Ther. 2025 Jun;11(2):177-193. doi: 10.1007/s41030-025-00291-5. Epub 2025 Mar 23.
5
Current Blood Eosinophilia Does Not Predict the Presence of Pulmonary Hypertension in Patients with End-Stage Lung Disease.目前的血液嗜酸性粒细胞增多不能预测终末期肺病患者是否存在肺动脉高压。
J Clin Med. 2025 Feb 9;14(4):1120. doi: 10.3390/jcm14041120.
6
Quantitative CT imaging characteristics of patients with chronic obstructive pulmonary disease with different eosinophil levels: a retrospective observational study using linked data from a tertiary hospital in China.不同嗜酸性粒细胞水平的慢性阻塞性肺疾病患者的定量CT成像特征:一项利用中国一家三级医院的关联数据进行的回顾性观察研究
BMJ Open. 2025 Feb 19;15(2):e088887. doi: 10.1136/bmjopen-2024-088887.
7
Incremental long-term benefit of drug therapies for chronic obstructive pulmonary disease in quality of life but not mortality: a network meta-analysis.药物治疗对慢性阻塞性肺疾病患者生活质量的长期增量效益而非死亡率:一项网状荟萃分析。
Arch Med Sci. 2024 May 28;20(5):1586-1596. doi: 10.5114/aoms/183025. eCollection 2024.
8
Increase in Blood Eosinophil Count Over Time and Sputum IL8 are Associated with FEV Decline in Asthma.随着时间的推移,血液嗜酸性粒细胞计数的增加和痰液 IL8 与哮喘患者的 FEV 下降有关。
Lung. 2024 Nov 30;203(1):8. doi: 10.1007/s00408-024-00760-9.
9
Diagnostic Challenges and Pathogenetic Differences in Biomass-Smoke-Induced versus Tobacco-Smoke-Induced COPD: A Comparative Review.生物质烟雾诱导与烟草烟雾诱导的慢性阻塞性肺疾病的诊断挑战和发病机制差异:一项比较性综述
Diagnostics (Basel). 2024 Sep 27;14(19):2154. doi: 10.3390/diagnostics14192154.
10
Blood eosinophil count correlates with alveolar damage in emphysema-predominant COPD.血嗜酸性粒细胞计数与肺气肿为主的 COPD 中的肺泡损伤相关。
BMC Pulm Med. 2024 Oct 13;24(1):510. doi: 10.1186/s12890-024-03320-2.
Matrix Biol. 2018 Nov;73:34-51. doi: 10.1016/j.matbio.2018.01.018. Epub 2018 Mar 23.
4
Further Studies of Unsuspected Emphysema in Nonsmoking Patients With Asthma With Persistent Expiratory Airflow Obstruction.非吸烟哮喘患者持续呼气气流阻塞中未被发现的肺气肿的进一步研究。
Chest. 2018 Mar;153(3):618-629. doi: 10.1016/j.chest.2017.11.016. Epub 2017 Nov 29.
5
Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort.痰和血嗜酸性粒细胞浓度与 COPD 严重程度的临床指标的关联:SPIROMICS 队列分析。
Lancet Respir Med. 2017 Dec;5(12):956-967. doi: 10.1016/S2213-2600(17)30432-0. Epub 2017 Nov 13.
6
Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease.美泊利珠单抗治疗嗜酸性粒细胞性慢性阻塞性肺疾病。
N Engl J Med. 2017 Oct 26;377(17):1613-1629. doi: 10.1056/NEJMoa1708208. Epub 2017 Sep 11.
7
Eosinophils in COPD: just another biomarker?COPD 中的嗜酸性粒细胞:仅仅是另一种生物标志物吗?
Lancet Respir Med. 2017 Sep;5(9):747-759. doi: 10.1016/S2213-2600(17)30217-5. Epub 2017 Jun 7.
8
New Anti-Eosinophil Drugs for Asthma and COPD: Targeting the Trait!用于哮喘和慢性阻塞性肺疾病的新型抗嗜酸性粒细胞药物:针对该特征!
Chest. 2017 Dec;152(6):1276-1282. doi: 10.1016/j.chest.2017.05.019. Epub 2017 Jun 2.
9
A pilot randomised clinical trial of mepolizumab in COPD with eosinophilic bronchitis.美泊利单抗治疗合并嗜酸性支气管炎的慢性阻塞性肺疾病的一项探索性随机临床试验。
Eur Respir J. 2017 Mar 15;49(3). doi: 10.1183/13993003.02486-2016. Print 2017 Mar.
10
Biomarkers of extracellular matrix turnover are associated with emphysema and eosinophilic-bronchitis in COPD.细胞外基质周转的生物标志物与慢性阻塞性肺疾病中的肺气肿和嗜酸性粒细胞性支气管炎相关。
Respir Res. 2017 Jan 19;18(1):22. doi: 10.1186/s12931-017-0509-x.